Label analysis is key to educating patients about risks of vitamin A-containing supplements.

Increase in dietary supplement use in the United States suggests a great need for clinicians to be aware of the range of their quality parameters.

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences.

Consider the origins of America’s cosmetic and supplement industry and the advertising practices that sustain it.

During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court.

Marissa Chaet Brykman joins Ethics Talk to discuss her article, coauthored with Dr Virginia Streusand Goldman, Dr Nandakumara Sarma, Dr Hellen A. Oketch-Rabah, Deborah Biswas and Dr Gabriel I. Giancaspro: “What Should Clinicians Know About Dietary Supplement Quality?”

Jorie Braunold joins Ethics Talk to discuss her article: “How Long Have Supplements Promised to Make Us Slim, Sexy, and Virile?”

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences.

Dr Amy B. Cadwallader, Joshua J. Klein, and Scott J. Schweikart join this episode of Ethics Talk to discuss safety and limited legal means of reining in social media influencers' advertisements about dietary supplements.